Welcome to our dedicated page for Artius II Acqsn SEC filings (Ticker: AACB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Artius II Acqsn's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Artius II Acqsn's regulatory disclosures and financial reporting.
Artius II Acquisition Inc. (AACB) filed its Q3 2025 report, showing a SPAC still in its search phase with sizeable funds in trust and standard SPAC expenses. The trust held $225,851,431 as of September 30, 2025, invested primarily in short‑term U.S. Treasuries. For the quarter, the company recorded net income of $2,210,556, driven by $2,451,396 of interest income; year‑to‑date results reflect a net loss of $750,481 after recognizing a $6,000,000 advisory fee.
The SPAC completed its IPO on February 14, 2025, issuing 22,000,000 units for gross proceeds of $220,000,000, alongside 175,000 private placement units for $1,750,000. Transaction costs totaled $7,537,261, including a deferred underwriting fee of $6,600,000. Cash outside the trust was $141,921 with a working capital surplus of $98,807 as of quarter‑end.
The company has until August 14, 2026 (or February 14, 2027 if a definitive agreement is executed) to consummate a business combination. Management disclosed that these timelines and limited operating cash raise substantial doubt about the company’s ability to continue as a going concern absent a completed transaction.
FAQ
What is the current stock price of Artius II Acqsn (AACB)?
What is the market cap of Artius II Acqsn (AACB)?
